Most of them occur in DLG or ETGE motifs, and the majority of them lead to the activation of the NRF2 pathway in cancer.36Additionally, we identified three cases of copy number amplification variant ofNFE2L2in LUSC, which also resulted in activation of the NRF2 pathway. The gene discussed is NFE2L2; the disease is cancer.